Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-10-035634
Filing Date
2010-07-01
Accepted
2010-07-01 20:01:38
Documents
2
Period of Report
2010-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd280495.html 3  
1 FORM 3 rrd280495.xml 3 2202
2 POWER OF ATTORNEY rrd251371_283640.htm EX-24. 2808
  Complete submission text file 0001181431-10-035634.txt   6986
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

EIN.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11-13, BOULEVARD DE LA FOIRE LUXEMBOURG N4 L-1528
Business Address 11-13, BOULEVARD DE LA FOIRE LUXEMBOURG N4 L-1528 00352-26478360
Sinaf S.A. (Reporting) CIK: 0001495790 (see all company filings)

State of Incorp.: N4 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-19825 | Film No.: 10932284